Oko-Test Dorożyńskisp. j.

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2004-09-24
Activity description

Oko-Test Dorożyński provides eye diagnostics and treatment, including cataract and eyelid surgery and intravitreal injections. Its centers in Nowy Targ and Olkusz also treat glaucoma, AMD/DME, dry eye syndrome, and eye conditions in children.

Registered address
Orzechówka 36, 32-300 Sieniczno, Poland
Website
Phone
Social media
Electronic delivery address
AE:PL-79290-28045-JBSBJ-25

Financials

3 of the last 5 financial statements were filed late.

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 4.35mMedianUSD 43.94kAverageUSD 313.84k
Net profit
This companyUSD 1.41mMedianUSD 924.93AverageUSD 51.12k
Operating costs
This companyUSD 2.89mMedianUSD 37.14kAverageUSD 249.66k
Assets
This companyUSD 1.93mMedianUSD 50.46kAverageUSD 336.85k

Industry

  • Publishing activities (22.1)
  • Printing (22.2)
  • Wholesale on a fee or contract basis (51.1)

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 438.4K

Public aid

PurposeGross amount
Regional investment aid
$437.3K
De minimis aid (in accordance with Commission Regulation 2023/2831)
$7,965
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$174.1K

European Funds

ProjectEU co-financing
Implementation of comprehensive medical services for anti-ageing and regenerative treatments for the face and body.
$445.2K

National Health Fund (NFZ) contracts

Oko-Test Dorożyński has been an NFZ healthcare provider since 2008. In 2026 it is performing 3 contracts with a total value of USD 3.47m. All its contracts were worth USD 27.46m in total.

NFZ contract value by year (in k USD)

Type of careNFZ branchContractsValue in 2026
Inpatient treatmentmałopolskie2USD 3.09m
Outpatient specialist caremałopolskie1USD 377.69k

NFZ waiting lists

This company's facilities run 10 NFZ waiting lists. Waiting time forecast by NFZ, as of 26.10.2026.

ServiceWaiting time
Treatment of patients with retinal diseases (AMD, DME)no wait
Glaucoma surgeryno wait
Treatment of patients with retinal diseases (AMD, DME)1 day
Treatment of patients with retinal diseases (AMD, DME)4 days
Lens procedures (cataract)15 days

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Ownership

Owner
Igor Wacław Dorożyński (65)
Wioletta Iwona Tomczyk Dorożyńska (59)

Manner of representation

Each partner may conduct the affairs of the partnership and represent it independently, unless the subject matter of the act is an act exceeding the ordinary management of the partnership. In the case of an act exceeding the ordinary management, the joint action of all partners is required.

Igor Wacław Dorożyński and Wioletta Iwona Tomczyk Dorożyńska – all partners share the same surname, so the structure looks family-owned.

Beneficial owners

Person

Competitors

Name
TVSsp. z o.o.
Develor Polskasp. z o.o.

Change history

DateEvent
2010-10-08PKD change
2009-12-31Name change
2006-11-28Name change
2004-09-24Entered in the register

FAQ

Last updated: 2026-07-17